[go: up one dir, main page]

IS2139B - Kvetíapínagnir - Google Patents

Kvetíapínagnir

Info

Publication number
IS2139B
IS2139B IS6308A IS6308A IS2139B IS 2139 B IS2139 B IS 2139B IS 6308 A IS6308 A IS 6308A IS 6308 A IS6308 A IS 6308A IS 2139 B IS2139 B IS 2139B
Authority
IS
Iceland
Prior art keywords
kvetíapínagnir
Prior art date
Application number
IS6308A
Other languages
English (en)
Icelandic (is)
Other versions
IS6308A (is
Inventor
Brown Daniel Boyd
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2139(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6308A publication Critical patent/IS6308A/is
Publication of IS2139B publication Critical patent/IS2139B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IS6308A 1999-09-21 2002-03-19 Kvetíapínagnir IS2139B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922271.3A GB9922271D0 (en) 1999-09-21 1999-09-21 Formulation
PCT/GB2000/003598 WO2001021179A1 (en) 1999-09-21 2000-09-18 Quetiapine granules

Publications (2)

Publication Number Publication Date
IS6308A IS6308A (is) 2002-03-19
IS2139B true IS2139B (is) 2006-08-15

Family

ID=10861288

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6308A IS2139B (is) 1999-09-21 2002-03-19 Kvetíapínagnir

Country Status (37)

Country Link
US (3) US6599897B1 (de)
EP (1) EP1218009B1 (de)
JP (1) JP2003509461A (de)
KR (1) KR100748823B1 (de)
CN (3) CN1188130C (de)
AR (1) AR032596A1 (de)
AT (1) ATE288272T1 (de)
AU (1) AU776292B2 (de)
BG (1) BG65469B1 (de)
BR (1) BR0014107A (de)
CA (1) CA2383131A1 (de)
CO (1) CO5180585A1 (de)
CZ (1) CZ301585B6 (de)
DE (1) DE60017923T2 (de)
DK (1) DK1218009T3 (de)
EE (1) EE200200150A (de)
EG (1) EG24226A (de)
ES (1) ES2235941T3 (de)
GB (2) GB9922271D0 (de)
HK (1) HK1047706B (de)
HU (1) HUP0203531A3 (de)
IL (2) IL148440A0 (de)
IS (1) IS2139B (de)
MX (1) MXPA02002627A (de)
MY (1) MY130208A (de)
NO (1) NO320908B1 (de)
NZ (1) NZ517549A (de)
PL (1) PL198824B1 (de)
PT (1) PT1218009E (de)
RU (1) RU2256453C2 (de)
SI (1) SI1218009T1 (de)
SK (1) SK286884B6 (de)
TR (1) TR200200716T2 (de)
TW (1) TWI226832B (de)
UA (1) UA73529C2 (de)
WO (1) WO2001021179A1 (de)
ZA (1) ZA200201709B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
EP1448169A1 (de) * 2001-11-07 2004-08-25 Fujisawa Pharmaceutical Co., Ltd. Methode zur verbesserung der löslichkeit von schwer-dispergierbaren medikamenten
JP4514473B2 (ja) * 2004-02-23 2010-07-28 富士通株式会社 コンピュータシステム、中央装置及びプログラム実行方法
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
EP1879874A2 (de) * 2005-04-21 2008-01-23 Medichem, S.A. Verfahren zur herstellung von quetiapin und quetiapinfumarat
EP1976487A2 (de) 2006-01-25 2008-10-08 Astron Research Limited Dosierung mit verzögerter freigabe von phenothiazin-derivaten mit kanalisierern
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
JP2009536665A (ja) * 2006-05-09 2009-10-15 アストラゼネカ・アクチエボラーグ （２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの新規な塩形態
US20090324717A1 (en) * 2006-07-28 2009-12-31 Farmaprojects, S. A. Extended release pharmaceutical formulation of metoprolol and process for its preparation
US20080085888A1 (en) * 2006-09-15 2008-04-10 Breining Scott R Therapeutic Combinations
US8623861B2 (en) * 2006-11-03 2014-01-07 Xin-Min Li Method of treating demyelination diseases
WO2008091592A1 (en) * 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
DE602007009036D1 (de) * 2007-02-14 2010-10-21 Lesvi Laboratorios Sl Pharmazeutische Zusammensetzungen mit Quetiapinfumarat
AU2009219286B2 (en) * 2008-02-27 2012-02-09 Intercontinental Great Brands Llc Multi-region confectionery
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
US20110183963A1 (en) 2009-12-31 2011-07-28 Travis Mickle Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
LT2544536T (lt) 2010-03-11 2019-02-25 Kempharm, Inc. Kvetiapino riebalų rūgšties konjugatai, jų gamybos būdas ir panaudojimas
WO2011146009A1 (en) 2010-05-20 2011-11-24 Targacept Inc. New process for the preparation of aryl substituted olefinic amines
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
KR20230029605A (ko) * 2020-04-29 2023-03-03 스테판 컴파니 아민, 양성자화 아민 또는 사차 암모늄 화합물을 함유하는 고형 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
EP0416773B1 (de) * 1989-08-31 1993-03-03 Takeda Chemical Industries, Ltd. Vitamin-B12-Zusammensetzung
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JPH06100602A (ja) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd 経口固形製剤およびその製造方法
US5397576A (en) * 1992-09-23 1995-03-14 Hoffmann-La Roche Inc. Spray triturated micronutrient compositions
BR9307387A (pt) * 1992-11-09 1999-08-31 Boots Co Plc Agentes terapêuticos
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
US5948437A (en) 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
CN1230883A (zh) * 1996-09-24 1999-10-06 伊莱利利公司 包衣颗粒制剂
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation

Also Published As

Publication number Publication date
EE200200150A (et) 2003-04-15
PT1218009E (pt) 2005-05-31
IL148440A0 (en) 2002-09-12
CZ2002974A3 (cs) 2002-06-12
BR0014107A (pt) 2002-08-20
CN1188130C (zh) 2005-02-09
DK1218009T3 (da) 2005-05-09
GB9922271D0 (en) 1999-11-17
CO5180585A1 (es) 2002-07-30
US20060159768A1 (en) 2006-07-20
KR100748823B1 (ko) 2007-08-13
GB0021406D0 (en) 2000-10-18
BG65469B1 (bg) 2008-09-30
EP1218009B1 (de) 2005-02-02
NO20021394L (no) 2002-03-20
NZ517549A (en) 2003-10-31
PL198824B1 (pl) 2008-07-31
DE60017923T2 (de) 2006-01-12
ZA200201709B (en) 2003-05-28
EG24226A (en) 2008-11-10
CN1899288A (zh) 2007-01-24
MXPA02002627A (es) 2002-07-30
TR200200716T2 (tr) 2002-06-21
US7022692B2 (en) 2006-04-04
HUP0203531A2 (hu) 2003-02-28
IL148440A (en) 2007-07-04
ES2235941T3 (es) 2005-07-16
SI1218009T1 (en) 2005-06-30
DE60017923D1 (de) 2005-03-10
AU7302300A (en) 2001-04-24
CN1626094A (zh) 2005-06-15
MY130208A (en) 2007-06-29
CA2383131A1 (en) 2001-03-29
CZ301585B6 (cs) 2010-04-21
US6599897B1 (en) 2003-07-29
HK1047706B (en) 2005-06-10
PL357369A1 (en) 2004-07-26
CN1331472C (zh) 2007-08-15
AR032596A1 (es) 2003-11-19
ATE288272T1 (de) 2005-02-15
HK1047706A1 (en) 2003-03-07
IS6308A (is) 2002-03-19
TWI226832B (en) 2005-01-21
CN1374867A (zh) 2002-10-16
BG106509A (en) 2002-12-29
WO2001021179A1 (en) 2001-03-29
SK286884B6 (sk) 2009-07-06
JP2003509461A (ja) 2003-03-11
RU2256453C2 (ru) 2005-07-20
SK3722002A3 (en) 2002-07-02
UA73529C2 (uk) 2005-08-15
NO320908B1 (no) 2006-02-13
HUP0203531A3 (en) 2004-12-28
US20040228914A1 (en) 2004-11-18
AU776292B2 (en) 2004-09-02
EP1218009A1 (de) 2002-07-03
KR20020033186A (ko) 2002-05-04
NO20021394D0 (no) 2002-03-20

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE60001240D1 (de) Laserdepiliergerät
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
NO20021394L (no) Quetiapingranuler
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
NO20020278D0 (no) Fosfattransportinhibitorer
DE50009570D1 (de) Wechselcorrugator
DE50015451D1 (de) Spülwannensystem
DE59910286D1 (de) Kniehebel-spannvorrichtung
DE50000805D1 (de) Aufsitzspanner
DE60000107D1 (de) Formschliessvorrichtung
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50012482D1 (de) Tibiamarknagel
DE50003660D1 (de) Diacylhydrazinderivate
DE60000940D1 (de) Wälzlagerstahl
DE59906520D1 (de) Exzenterzahnradgetriebe
DE50003259D1 (de) Textilie
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50009208D1 (de) Hydroxyphenylvinylthiazole
ATE440824T1 (de) Nitro-sulfobenzamide